Wide variability and inconsistency in reporting of results of Myelodysplastic Syndromes/neoplasms (MDS) clinical trials: An icMDS systematic review of published manuscripts
Ted M. Getz(Yale Cancer Center), Klaus H. Metzeler(University Hospital Leipzig), Rami S. Komrokji(Moffitt Cancer Center), Gail J. Roboz(Cornell University), Uma Borate(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hetty E. Carraway(Cleveland Clinic), Jane E. Churpek(University of Wisconsin–Madison), Stephen D. Nimer(University of Miami), Fabio Efficace(Fondazione Gimema Onlus), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Robert P. Hasserjian(Massachusetts General Hospital), David A. Sallman(Moffitt Cancer Center), Naval Daver(The University of Texas MD Anderson Cancer Center), Amy E. DeZern(Johns Hopkins University), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center), Tariq Kewan(Yale University), Peter L. Greenberg(Stanford University), Eric Padron(Moffitt Cancer Center), Jacqueline Boultwood(University of Oxford), Rena Buckstein(Sunnybrook Health Science Centre), Shahram Kordasti(Guy's Hospital), Zhuoer Xie(Mayo Clinic), Michael R. Savona(Vanderbilt University), Richard F. Little(Dana-Farber Cancer Institute), Matteo Della Porta(University of Milan), Guillermo Sanz(Instituto de Salud Carlos III), Stephanie Halene(Yale Cancer Center), Mikkael A. Sekeres(University of Miami), Sanam Loghavi(The University of Texas MD Anderson Cancer Center), Tae Kon Kim(Vanderbilt University), Olatoyosi Odenike(University of Chicago), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Christopher S. Hourigan(National Heart Lung and Blood Institute), John M. Bennett(University of Rochester Medical Center), Alan F. List(TE Laboratories (Ireland)), Mina L. Xu(Yale Cancer Center), Mrinal M. Patnaik(Mayo Clinic), Ravindra Majeti(Stanford University), Uwe Platzbecker(National Center for Tumor Diseases), Andrew M. Brunner(Massachusetts General Hospital), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Justin Taylor(Medical University of South Carolina), Adrián Mosquera Orgueira(Complejo Hospitalario Universitario de Santiago), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Steven D. Gore(Yale Cancer Center), Pierre Fenaux(Université Paris Cité), Rafael Bejar(National Foundation for Cancer Research), Andrew H. Wei(The Royal Melbourne Hospital), Kelly Pugh(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), María E. Figueroa(University of Miami)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k